Drug
Procrit
Procrit is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated1
Completed1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
terminated133%
completed133%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnphase_2
Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations
NCT00624312
completedphase_3
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
NCT00656448
terminatedphase_2
Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
NCT00210626
Clinical Trials (3)
Showing 3 of 3 trials
NCT00624312Phase 2
Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations
NCT00656448Phase 3
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
NCT00210626Phase 2
Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3